Occasional heroin use by HIV-positive patients may be particularly harmful to the immune system and worsens HIV disease, compared to persistent or no heroin use, an international team of researchers reports.
19 hours ago | Science Daily
Kiev may be facing an unprecedented tuberculosis crisis. This is according to Larissa Kanarovskaya, the Head of the Kiev City Union of health workers. On December 1, 2014, at a press conference (a video in Russian can be seen here), she announced that on the average, 100 people die every day in Ukraine’s capital, of which one case is from active tuberculosis.
19 hours ago | TB Europe Coalition
Restrictive policies that can sometimes prevent people from keeping their jobs could be compromising the effectiveness of Global Fund-supported opioid substitution therapy programs across Eastern Europe and Central Asia, civil society representatives from around the region told Aidspan.
15 December 2014 | Aidspan
Belarus aims to sustain and scale up its HIV prevention programme for people who inject drugs. Today, more than 1000 people who used to inject drugs are enrolled on the OST programme, which is available at 18 sites. Clients go every day to a participating health clinic to take a dose of methadone, which helps to treat their addiction to opiates.
15 December 2014 | UNAIDS
The EMCDDA warns that new HIV infections related to the injection of drugs – including stimulants – have been reported in many countries, particularly in Eastern Europe. Of particular concern is the fact that many of the injecting-related cases in Europe are detected too late. Special attention should be given to providing these often hard-to-reach groups of drug users with adequate prevention messages, early diagnosis and treatment referral and to scaling up effective integrated harm reduction measures.
02 December 2014 | EMCDDA
UNITAID has published its 2014 HIV Preventives Technology and Market Landscape which shows that although there has been a significant increase in products with promise to curb HIV transmission, scaling up access to them has been slow due to a variety of issues including affordability, availability and demand – all market based. The report highlights opportunities to change this through efforts to reduce various market obstacles such as the lack of product approval completion.
01 December 2014 | UNITAID
Handing the reins to the Department of Health might seem a liberal-minded approach, but it could mean less is spent on treatment. Drug use simply doesn’t cause as much ill-health as other risky behaviours, so isn't prioritised by health officials. But it is seen as a major cause of crime.
25 November 2014 | The Guardian
A response to the Secretary of State for Work and Pensions' article "Now fight the methadone industry that keeps addicts hooked".
25 November 2014 | DrugScope
Last year nearly 700,000 Americans took the drug, twice as many as a decade ago. It is now more popular than crack, by some measures. What explains heroin’s return?
24 November 2014 | The Economist
Fifteen years of research into Vancouver’s needle and syringe programme leads to the conclusion that such programmes can stop the spread of HIV and do not increase harms. However, they can only be effective if their policies allow sufficient sterile equipment to be distributed to ensure injectors always have fresh supplies.
21 November 2014 | Drug & Alcohol Findings